🔗 Share this article

The Nobel Prize in medical science was granted for transformative findings that illuminate how the body's defense network attacks dangerous infections while protecting the healthy tissues.

A trio of esteemed researchers—Japan's Shimon Sakaguchi and American scientists Mary Brunkow and Dr. Ramsdell—share this accolade.

The research identified specialized "security guards" within the defense system that eliminate rogue defense cells capable of harming the organism.

The findings are now paving the way for new treatments for autoimmune diseases and cancer.

These winners will share a prize fund valued at 11 million SEK.

Decisive Discoveries

"Their work has been decisive for understanding how the body's defenses functions and the reason we do not all develop severe self-attack conditions," stated the chair of the award panel.

This team's research explain a core question: How does the immune system protect us from numerous invaders while keeping our healthy cells unharmed?

Our body's protection system employs white blood cells that search for indicators of infection, including viruses and germs it has never encountered.

These cells utilize sensors—known as recognition units—that are generated randomly in a vast number of variations.

This gives the immune system the ability to combat a wide array of threats, but the randomness of the mechanism unavoidably creates white blood cells that can target the body.

Security Guards of the Body

Researchers earlier knew that a portion of these harmful white blood cells were destroyed in the immune organ—the site where white blood cells mature.

The latest Nobel Prize recognizes the discovery of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the body to neutralize other defenders that attack the healthy cells.

We know that this mechanism fails in autoimmune diseases such as type-1 diabetes, MS, and rheumatoid arthritis.

The prize committee stated, "The discoveries have laid the foundation for a novel area of investigation and spurred the development of innovative treatments, for example for cancer and autoimmune diseases."

In malignancies, T-regs block the body from fighting the growth, so research are focused on reducing their quantity.

For autoimmune diseases, experiments are exploring boosting regulatory T-cells so the organism is not being harmed. A similar method could also be useful in minimizing the chances of transplanted organ failure.

Pioneering Studies

Professor Shimon Sakaguchi, of Osaka University, conducted experiments on mice that had their thymus extracted, causing autoimmune disease.

He showed that introducing immune cells from healthy animals could prevent the disease—implying there was a mechanism for preventing immune cells from harming the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an inherited immune disorder in mice and humans that led to the identification of a gene critical for how T-regs operate.

"Their groundbreaking research has revealed how the immune system is controlled by T-reg cells, stopping it from mistakenly targeting the body's own tissues," said a prominent physiology specialist.

"The work is a striking example of how fundamental biological study can have broad implications for human health."